AKT1 and cancer: Among the top 10 enriched pathways, Proteoglycans in cancer, HIF-1 signalling pathway, and PI3K-Akt signalling pathway were all reported to participate in immune cell signalling in recently reports13–15, suggesting a potential relationship between EMT and immunity (Fig. 2a).